Membrane polysaccharide of bacterial origin useful as a immunostiulant and having the following quantitative analytical composition: ______________________________________
galactose content 66 ± 6%
content of hexoses other than galactose
<1%
hexosamine (glucosamine) content
8.5 ± 2%
amino acid content 5 ± 2%
fatty acid content <1%
nucleic acid content <0.005%
protein content <0.3%
and molecular weight: 90,000 ± 10,000.
______________________________________
Claim 2
Dependent Claim
59 words
Membrane polysaccharide of bacterial origin useful as a immunostiulant and having the following quantitative analytical composition: ______________________________________
galactose content 66 ± 6%
content of hexoses other than galactose
<1%
hexosamine (glucosamine) content
8.5 ± 2%
amino acid content 5 ± 2%
fatty acid content <1%
nucleic acid content <0.005%
protein content <0.3%
and molecular weight: 90,000 ± 10,000.
______________________________________
Claim 3
Dependent Claim
35 words
Polysaccharide of molecular weight of about 60,000±10,000 daltons and having a polymeric structure comprising of about 40±7 repeating units of the monomer: ##STR3## where Gal f =galactofuranose Gal p =galactopyranose (in α and β form).
Claim 4
Dependent Claim
35 words
Polysaccharide of molecular weight of about 60,000±10,000 daltons and having a polymeric structure comprising of about 40±7 repeating units of the monomer: ##STR3## where Gal f =galactofuranose Gal p =galactopyranose (in α and β form).
Claim 5
Dependent Claim
20 words
Polysaccharide as claimed in claim 2, in which the monomer is represented by the structural formula: ##STR4## where x=1; y=6.
Claim 6
Dependent Claim
21 words
Pharmaceutical composition useful as an immunostimulant comprising an effective amount of the polysaccharide of claim 1, together with pharmaceutically acceptable carrier.
Claim 7
Dependent Claim
11 words
The composition of claim 4, which further contains a vaccinating agent.